Adam P. Buzby

1.4k total citations
16 papers, 848 citations indexed

About

Adam P. Buzby is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Adam P. Buzby has authored 16 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Virology, 11 papers in Immunology and 7 papers in Infectious Diseases. Recurrent topics in Adam P. Buzby's work include HIV Research and Treatment (15 papers), Immune Cell Function and Interaction (9 papers) and HIV/AIDS Research and Interventions (4 papers). Adam P. Buzby is often cited by papers focused on HIV Research and Treatment (15 papers), Immune Cell Function and Interaction (9 papers) and HIV/AIDS Research and Interventions (4 papers). Adam P. Buzby collaborates with scholars based in United States, United Kingdom and Austria. Adam P. Buzby's co-authors include Norman L. Letvin, Yue Sun, John R. Mascola, Gary J. Nabel, Srinivas S. Rao, Jörn E. Schmitz, Zhi-Yong Yang, David C. Montefiori, Ling Xu and Brianne R. Barker and has published in prestigious journals such as Science, Nature Medicine and Journal of Virology.

In The Last Decade

Adam P. Buzby

15 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam P. Buzby United States 12 679 524 263 222 212 16 848
Jim Tartaglia United States 16 601 0.9× 545 1.0× 286 1.1× 202 0.9× 230 1.1× 19 897
Georgia R. Krivulka United States 11 776 1.1× 644 1.2× 256 1.0× 283 1.3× 297 1.4× 11 1.0k
Zimra R. Israel United States 16 539 0.8× 489 0.9× 304 1.2× 236 1.1× 206 1.0× 21 888
Brent Welcher United States 11 560 0.8× 498 1.0× 263 1.0× 475 2.1× 225 1.1× 12 1.0k
Marie‐Claire Gauduin United States 15 812 1.2× 583 1.1× 258 1.0× 338 1.5× 160 0.8× 24 986
Kaifan Dai United States 5 735 1.1× 522 1.0× 327 1.2× 307 1.4× 340 1.6× 6 1.1k
Rebecca Shoemaker United States 5 453 0.7× 451 0.9× 303 1.2× 205 0.9× 160 0.8× 15 785
Russell D. Schmidt United States 12 776 1.1× 438 0.8× 261 1.0× 290 1.3× 337 1.6× 15 1.0k
Tiphaine Blanchard France 6 491 0.7× 309 0.6× 252 1.0× 176 0.8× 176 0.8× 16 670
Annalena La Porte United States 8 553 0.8× 451 0.9× 242 0.9× 204 0.9× 320 1.5× 11 864

Countries citing papers authored by Adam P. Buzby

Since Specialization
Citations

This map shows the geographic impact of Adam P. Buzby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam P. Buzby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam P. Buzby more than expected).

Fields of papers citing papers by Adam P. Buzby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam P. Buzby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam P. Buzby. The network helps show where Adam P. Buzby may publish in the future.

Co-authorship network of co-authors of Adam P. Buzby

This figure shows the co-authorship network connecting the top 25 collaborators of Adam P. Buzby. A scholar is included among the top collaborators of Adam P. Buzby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam P. Buzby. Adam P. Buzby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ejemel, Monir, Thomas A. Smith, L. Greenberg, et al.. (2022). A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis. Scientific Reports. 12(1). 9403–9403. 12 indexed citations
2.
Asmal, Mohammed, Gabrielle Nickel, Jimmy D. Dikeakos, et al.. (2016). Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections. Virology. 499. 298–312. 4 indexed citations
3.
Santra, Sampa, Mark Muldoon, Sydeaka Watson, et al.. (2012). Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens. Virology. 428(2). 121–127. 38 indexed citations
4.
Yeh, Wendy W., Srinivas S. Rao, So‐Yon Lim, et al.. (2011). The TRIM5 Gene Modulates Penile Mucosal Acquisition of Simian Immunodeficiency Virus in Rhesus Monkeys. Journal of Virology. 85(19). 10389–10398. 36 indexed citations
5.
Santra, Sampa, Hua‐Xin Liao, Ruijin Zhang, et al.. (2010). Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys. Nature Medicine. 16(3). 324–328. 185 indexed citations
6.
Sun, Yue, Sampa Santra, Adam P. Buzby, et al.. (2010). Recombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys. Virology. 406(1). 48–55. 8 indexed citations
7.
Cayabyab, Mark J., Birgit Korioth-Schmitz, Yue Sun, et al.. (2009). RecombinantMycobacterium bovisBCG Prime-Recombinant Adenovirus Boost Vaccination in Rhesus Monkeys Elicits Robust Polyfunctional Simian Immunodeficiency Virus-Specific T-Cell Responses. Journal of Virology. 83(11). 5505–5513. 32 indexed citations
8.
Yeh, Wendy W., Mohammed Asmal, Srinivas S. Rao, et al.. (2009). Partial Protection of Simian Immunodeficiency Virus (SIV)-Infected Rhesus Monkeys against Superinfection with a Heterologous SIV Isolate. Journal of Virology. 83(10). 5293–5293. 1 indexed citations
9.
Yeh, Wendy W., Mohammed Asmal, Srinivas S. Rao, et al.. (2009). Partial Protection of Simian Immunodeficiency Virus (SIV)-Infected Rhesus Monkeys against Superinfection with a Heterologous SIV Isolate. Journal of Virology. 83(6). 2686–2696. 26 indexed citations
10.
Zahn, Roland, Melisa D. Rett, Birgit Korioth-Schmitz, et al.. (2008). Simian Immunodeficiency Virus (SIV)-Specific CD8+T-Cell Responses in Vervet African Green Monkeys Chronically Infected with SIVagm. Journal of Virology. 82(23). 11577–11588. 30 indexed citations
11.
Letvin, Norman L., Adam P. Buzby, Birgit Korioth-Schmitz, et al.. (2007). No Evidence for Consistent Virus-Specific Immunity in Simian Immunodeficiency Virus-Exposed, Uninfected Rhesus Monkeys. Journal of Virology. 81(22). 12368–12374. 46 indexed citations
12.
Permar, Sallie R., Srinivas S. Rao, Yue Sun, et al.. (2007). Clinical Measles after Measles Virus Challenge in Simian Immunodeficiency Virus–Infected Measles Virus–Vaccinated Rhesus Monkeys. The Journal of Infectious Diseases. 196(12). 1784–1793. 3 indexed citations
13.
Sun, Yue, Sallie R. Permar, Adam P. Buzby, & Norman L. Letvin. (2007). Memory CD4 + T-Lymphocyte Loss and Dysfunction during Primary Simian Immunodeficiency Virus Infection. Journal of Virology. 81(15). 8009–8015. 27 indexed citations
15.
Letvin, Norman L., John R. Mascola, Yue Sun, et al.. (2006). Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys. Science. 312(5779). 1530–1533. 287 indexed citations
16.
Sun, Yue, Jörn E. Schmitz, Adam P. Buzby, et al.. (2006). Virus-Specific Cellular Immune Correlates of Survival in Vaccinated Monkeys after Simian Immunodeficiency Virus Challenge. Journal of Virology. 80(22). 10950–10956. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026